We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

News · March 19, 2021

Marine Omega-3 Fatty Acid, Vitamin D Do Not Cut Risk for A-Fib

Treatment with EPA-DHA or vitamin D3 supplement versus placebo results in no significant difference in incident atrial fibrillation over five years



Further Reading